Test Your Knowledge of RCC Research Presented at ESMO!
Do you remember the RCC research presented at ESMO 2024? Test your knowledge now and see how you rank!
Do you remember the RCC research presented at ESMO 2024? Test your knowledge now and see how you rank!
A curated eBook featuring ESMO 2024 RCC-focused studies, findings, and expert opinions.
Real-world evidence from this study suggests that ICI-TKI combinations may be optimal for intermediate-risk mRCC.
Physician’s Weekly reviewed renal cell carcinoma-targeted research presented at the 2024 ESMO annual meeting.
During the 2024 annual ESMO Congress, multiple poster sessions focused on the treatment of renal cell carcinoma (RCC).
Protein glycosylation may predict response to NIVO+CABO vs SUN in aRCC, with glycopeptides and complement proteins linked to progression-free survival and outcomes.
The SUNNIFORECAST trial (LBA75), presented by Dr. Lothar Bergmann from Germany on Friday,...
Let us know if you attended ESMO 2024 in person.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.